Merck KGaA (FRA:MRK)
Germany · Delayed Price · Currency is EUR | Market Cap | 48.78B |
| Revenue (ttm) | 21.22B |
| Net Income (ttm) | 2.86B |
| Shares Out | n/a |
| EPS (ttm) | 6.59 |
| PE Ratio | 17.04 |
| Forward PE | 12.88 |
| Dividend | 2.20 (1.97%) |
| Ex-Dividend Date | Apr 28, 2025 |
| Volume | 25 |
| Average Volume | 3,073 |
| Open | 111.25 |
| Previous Close | 111.00 |
| Day's Range | 110.00 - 111.80 |
| 52-Week Range | 101.15 - 167.20 |
| Beta | n/a |
| RSI | 48.06 |
| Earnings Date | Nov 13, 2025 |
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables, devices, instruments, software, and services for research, production, and testing; process solutions consisting of filtration devices, chromatography... [Read more]
Financial Performance
In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.
Financial StatementsNews
Merck KGaA Reaches Deal With U.S. To Cut Prices On IVF Drugs
(RTTNews) - Merck KGaA (MKKGY) announced that its U.S. and Canadian healthcare division, EMD Serono, has entered into an agreement with President Donald J. Trump's administration to broaden access to ...
Merck KGaA (MKGAF) Offers Major IVF Discount in New US Deal
Merck KGaA (MKGAF) Offers Major IVF Discount in New US Deal
Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs.
President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA, that aims to cut the out-of-pocket costs for in vitro fertilization, with the move com...
Trump announces efforts to expand access to IVF drugs
President Donald Trump announced two new efforts to expand availability of in vitro fertilization, the first concrete step from the Trump administration on the expensive, decades-old procedure. It inc...
Trump Announces Deal With Germany's Merck on IVF Costs
President Donald Trump announces a deal with Germany's Merck KGaA to cut the price of some of its fertility medicines in exchange for relief from threatened tariffs. He speaks during a a press confere...
Germany's Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets
The company confirmed its 2025 guidance and is targeting annual organic sales growth in the mid-single-digit percentage range and an expansion in profitability over the medium term.
Germany's Merck tweaks mid-term healthcare unit guidance
German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on Thursday.
EQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Merck KGaA Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 14.10.2...
Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™
Delray Beach, FL,, Oct. 08, 2025 (GLOBE NEWSWIRE) -- formation, and contamination risks threaten sample viability. Ensuring consistent global transportation standards will be a key differentiator for ...
Senator Rasha Kelej Received Senegal First Lady at the 7th Edition of Merck Foundation First Ladies Initiative Summit to Discuss the Impact of Their Joint Programs to Build Healthcare Capacity and Address Social and Health Issues
Business Wire India Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. It was inaugurate...
Chinese police investigating app fraud case, says German drugmaker Merck KGaA
Police in China are investigating an app fraud case, said German healthcare firm Merck KGaA , amid growing concerns over entities claiming affiliation with major corporations.
Merck and Siemens Deepen Strategic Partnership to Accelerate AI and Data-Driven Drug Discovery and Development
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, and Siemens, a leading technology company, signed a new Memorandum of Understanding (MoU), extending their strateg...
Senator Dr. Rasha Kelej Welcomes Nigeria First Lady at the 7th Edition of Their First Ladies Initiative Summit to Discuss Their Joint Programs to Build Healthcare Capacity, Break Infertility Stigma and Support Girl Education
Business Wire India Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. It was inaugurate...
Merck Foundation CEO and Mozambique First Lady Sign MoU to Underscore Their Long-Term Partnership to Strengthen Healthcare Capacity During the Merck Foundation First Ladies Initiative Summit 2025
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. Business Wire India Merck Foundation,...
Senator Rasha Kelej Received Maldives First Lady at the 7th Edition of Merck Foundation First Ladies Initiative Summit to Discuss Their Joint Programs to Build Healthcare Capacity
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. Business Wire India Merck Foundation,...
Senator Rasha Kelej Received Kenya First Lady at the 7th Edition of Merck Foundation First Ladies Initiative Summit to Discuss Their Joint Programs to Build Healthcare Capacity
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. Business Wire India Merck Foundation,...
Merck Foundation CEO, Dr. Rasha Kelej Welcomed First Lady of Central African Republic at the 7th Edition of Merck Foundation First Ladies Initiative 2025
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. Business Wire India Merck Foundation,...
Merck Foundation CEO Meets the First Lady of Cabo Verde & 13 African and Asian First Ladies of Africa at the Merck Foundation First Ladies Initiative Summit 2025
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. It was inaugurated by Prof. Dr. Frank...
Merck Foundation CEO Meets Zimbabwe First Lady & 13 First Ladies of Africa and Asia at the 7th Edition of Merck Foundation First Ladies Initiative Summit to Discuss the Strategy to Build Healthcare Capacity and Support Girl Education
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. Business Wire India Merck Foundation,...
Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
BEIJING — Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovativ...
Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drug...
Merck KGaA, Darmstadt, Germany, Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector
DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Ch...
mRNA Biotechs - Long-Term Value Risks Abound
mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c...
European Commission Grants Approval of OGSIVEO (nirogacestat) for the Treatment of Adults with Desmoid Tumors
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc....